Liposome-mediated suicide gene therapy in humans (Q45274513)

11 December 2017

Liposome-mediated suicide gene therapy in humans (English)

1 reference

11 December 2017

0 references

0 references

Regina C Reszka

1

1 reference

11 December 2017

Andreas Jacobs

series ordinal

2

1 reference

11 December 2017

Jürgen Voges

series ordinal

3

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

11 December 2017

Methods in Enzymology

1 reference

11 December 2017

391

1 reference

11 December 2017

200-208

1 reference

Cationic lipid-based delivery system for systemic cancer gene therapy

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Real-time quantitative polymerase chain reaction to assess gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Improved cationic lipid formulations for in vivo gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Quantification of hepatitis C virus by TaqMan PCR: comparison with HCV Amplicor Monitor assay

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Virus treatment questioned after gene therapy death

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Gene therapy's growing pains

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Antiviral activity and mechanism of action of ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Immunotherapy for cancer by direct gene transfer into tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Tumor-targeted gene transfer with DNA polyplexes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Non-viral vectors in cancer gene therapy: principles and progress

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Application of advances in molecular biology to the treatment of brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

For gene therapy, now-quantified risks are deemed troubling

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Clinical protocol. Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991012-4

7 January 2021

10.1016/S0076-6879(05)91012-4

Identifiers

DOI

1 reference

11 December 2017

1 reference